Access to anti-retroviral drugs, female in Guatemala
Guatemala: Access to anti-retroviral drugs, female was 73.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Guatemala, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
Guatemala recorded 73.0% for access to anti-retroviral drugs, female in 2024.
That represents a change of down 6.4% on the previous year and up 9.0% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Guatemala peaked at 78.0% in 2023 and was at its lowest, 0.0%, in 2000.
Guatemala ranks 71st of 141 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Guatemala, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 3.0% | — |
| 2004 | 3.0% | +0.0% |
| 2005 | 6.0% | +100.0% |
| 2006 | 10.0% | +66.7% |
| 2007 | 18.0% | +80.0% |
| 2008 | 29.0% | +61.1% |
| 2009 | 34.0% | +17.2% |
| 2010 | 38.0% | +11.8% |
| 2011 | 52.0% | +36.8% |
| 2012 | 54.0% | +3.8% |
| 2013 | 63.0% | +16.7% |
| 2014 | 67.0% | +6.3% |
| 2015 | 63.0% | -6.0% |
| 2016 | 62.0% | -1.6% |
| 2017 | 65.0% | +4.8% |
| 2018 | 68.0% | +4.6% |
| 2019 | 70.0% | +2.9% |
| 2020 | 68.0% | -2.9% |
| 2021 | 70.0% | +2.9% |
| 2022 | 73.0% | +4.3% |
| 2023 | 78.0% | +6.8% |
| 2024 | 73.0% | -6.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 10.3% | 0.0% | 34.0% | 10 |
| 2010s | 60.2% | 38.0% | 70.0% | 10 |
| 2020s | 72.4% | 68.0% | 78.0% | 5 |
Countries ranked near Guatemala
More gender data for Guatemala
- Child population (UN estimates and projections) 5,681 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -0.5138 % change on previous year (2030)
- Population 14,386 (2030)
- Working-age population (UN estimates and projections) 14,386 (2030)
- Population (UN estimates and projections), annual growth rate 2.14 % change on previous year (2030)
- Age population, age 00, female, interpolated 183,639 (2025)
- Age population, age 00, male, interpolated 190,265 (2025)
- Age population, age 01, female, interpolated 182,353 (2025)
- Age population, age 01, male, interpolated 188,776 (2025)
- Age population, age 02, female, interpolated 181,168 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Guatemala?
- Access to anti-retroviral drugs, female in Guatemala was 73.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Guatemala?
- The highest recorded value was 78.0% in 2023.
- What is the lowest access to anti-retroviral drugs, female recorded in Guatemala?
- The lowest recorded value was 0.0% in 2000.
- How does Guatemala rank for access to anti-retroviral drugs, female?
- Guatemala ranks 71st out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Guatemala?
- Over the last ten years it is up 9.0%. The long-run trend across the full record is volatile.
- Where does this Guatemala data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.